ArticleBMC public health2026
HPV vaccine awareness, perceptions, uptake, and school-based information channels during Nigeria's national rollout: a cross-sectional study among adolescent girls in rural Oyo State.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNigeria introduced the human papillomavirus (HPV) vaccine into its national routine immunisation programme in October 2023, using a phased delivery strategy that included school- and community-based platforms. Evidence remains limited on how adolescent girls in rural communities understand HPV vaccination during active rollout. This study assessed awareness, knowledge, perceptions, self-reported HPV vaccine uptake, and willingness to receive the vaccine among adolescent girls in rural Oyo State during the Phase-2 national rollout.
methodsWe conducted a school-based cross-sectional survey among 441 in-school adolescent girls recruited from 12 public and private secondary schools across three rural local government areas of Oyo State between 26 May and 19 June 2024. Structured questionnaires measured knowledge of cervical cancer, HPV, and HPV vaccination, as well as perceptions, beliefs, and self-reported vaccination status. Multivariable binary logistic regression was used to identify factors associated with HPV vaccine uptake and willingness to be vaccinated.
resultsAwareness of cervical cancer (26.1%), HPV (28.8%), and HPV vaccination (29.0%) was low. Schools were the most frequently reported source of information on cervical cancer and HPV among those who had heard of them. Forty-one participants (9.3%) self-reported having received the HPV vaccine. In adjusted analysis, favourable vaccine perception was strongly associated with self-reported uptake (AOR = 11.00; 95% CI: 3.53-34.25; p < 0.001), although this estimate should be interpreted cautiously because the vaccinated subgroup was small. Among unvaccinated participants, lack of information (49.3%), low perceived risk (20.3%), and concerns about side effects (16.0%) were the most frequently reported reasons for non-vaccination. Definite willingness to be vaccinated was associated with favourable vaccine perception (AOR = 6.24; 95% CI: 3.16-12.33; p < 0.001).
conclusionsDuring Nigeria's HPV vaccine rollout, self-reported uptake among adolescent girls in rural Oyo State was low and was associated more consistently with favourable vaccine perceptions than with knowledge measures alone. The findings suggest the potential value of strengthening school-based communication, providing adolescent-appropriate information, and considering parent/guardian engagement as part of rural HPV vaccination implementation. Because the study was cross-sectional and vaccination status was primarily self-reported, findings should be interpreted as associations rather than causal effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.